Cytek Biosciences, Inc. (CTKB) — Stock Valuation & Research

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications…

CTKB key statistics

Price$5.20
Market cap$670.92M
SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
52-week range3.28-6.18
Beta1.19

Explore CTKB's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.